apc-labelled antibodies targeting cd16 Search Results


cd16  (Miltenyi Biotec)
95
Miltenyi Biotec cd16
Cd16, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd16/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
cd16 - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier
fcγrⅲ antibody  (Sino Biological)
90
Sino Biological fcγrⅲ antibody
Fcγrⅲ Antibody, supplied by Sino Biological, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fcγrⅲ antibody/product/Sino Biological
Average 90 stars, based on 1 article reviews
fcγrⅲ antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
antibody reagent bd multitest cd3 fitc/cd8 pe/cd45 percp/cd4 apc  (Becton Dickinson)
90
Becton Dickinson antibody reagent bd multitest cd3 fitc/cd8 pe/cd45 percp/cd4 apc
Antibody Reagent Bd Multitest Cd3 Fitc/Cd8 Pe/Cd45 Percp/Cd4 Apc, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibody reagent bd multitest cd3 fitc/cd8 pe/cd45 percp/cd4 apc/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
antibody reagent bd multitest cd3 fitc/cd8 pe/cd45 percp/cd4 apc - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
pe-labeled anti-cd4  (Thermo Fisher)
90
Thermo Fisher pe-labeled anti-cd4
Pe Labeled Anti Cd4, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pe-labeled anti-cd4/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
pe-labeled anti-cd4 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
panel 1  (Miltenyi Biotec)
96
Miltenyi Biotec panel 1
Panel 1, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/panel 1/product/Miltenyi Biotec
Average 96 stars, based on 1 article reviews
panel 1 - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
apc vio770 conjugated anti cd16  (Miltenyi Biotec)
95
Miltenyi Biotec apc vio770 conjugated anti cd16
Apc Vio770 Conjugated Anti Cd16, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/apc vio770 conjugated anti cd16/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
apc vio770 conjugated anti cd16 - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier
rat anti mouse cd16 cd32  (Miltenyi Biotec)
95
Miltenyi Biotec rat anti mouse cd16 cd32
Rat Anti Mouse Cd16 Cd32, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rat anti mouse cd16 cd32/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
rat anti mouse cd16 cd32 - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier
cd19-bv421  (Becton Dickinson)
90
Becton Dickinson cd19-bv421
Cd19 Bv421, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd19-bv421/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
cd19-bv421 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
anti human cd16 apc mhcd1605  (Thermo Fisher)
86
Thermo Fisher anti human cd16 apc mhcd1605
Anti Human Cd16 Apc Mhcd1605, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti human cd16 apc mhcd1605/product/Thermo Fisher
Average 86 stars, based on 1 article reviews
anti human cd16 apc mhcd1605 - by Bioz Stars, 2026-03
86/100 stars
  Buy from Supplier
multitesttm 6-color tbnk  (Becton Dickinson)
90
Becton Dickinson multitesttm 6-color tbnk
<t> T-, B- and </t> NK-lymphocyte subpopulation relative and absolute counts at baseline in survivors and nonsurvivors.
Multitesttm 6 Color Tbnk, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/multitesttm 6-color tbnk/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
multitesttm 6-color tbnk - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
cd16 apce780 ebiocb16  (Thermo Fisher)
90
Thermo Fisher cd16 apce780 ebiocb16
<t> T-, B- and </t> NK-lymphocyte subpopulation relative and absolute counts at baseline in survivors and nonsurvivors.
Cd16 Apce780 Ebiocb16, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd16 apce780 ebiocb16/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
cd16 apce780 ebiocb16 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


T-, B- and NK-lymphocyte subpopulation relative and absolute counts at baseline in survivors and nonsurvivors.

Journal: Scientific Reports

Article Title: Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in SARS-CoV-2 infected patients: a single center study

doi: 10.1038/s41598-021-90983-0

Figure Lengend Snippet: T-, B- and NK-lymphocyte subpopulation relative and absolute counts at baseline in survivors and nonsurvivors.

Article Snippet: Lymphocyte subpopulations were assessed using BD Multitest™ 6-color TBNK (FITC-labeled CD3 clone SK7; PE-labeled CD16, clone B73.1, and CD56, clone NCAM 16.2; PerCP-Cy™5.5-labeled CD45, clone 2D1; PE-Cy™7-labeled CD4, clone SK3; APC-labeled CD19, clone SJ25C1; APC-Cy7-labeled CD8, clone SK1) and BD Trucount™ tubes for absolute count with a lyse-no-wash procedure (BD FACS™Lysing Solution).

Techniques:

ROC analysis of T-lymphocyte subset absolute counts for in-hospital mortality and disease severity of COVID-19 patients. Receiver operating characteristic (ROC) curves are represented for total CD3+ and four subsets of T lymphocyte cells. Cutoff values were identified with the Youden’s index. ( A ) ROC analysis showing the performance of baseline absolute counts of total T lymphocyte and their subsets in distinguishing fatal cases from survivors. Cutoff values for: CD3+: 524 cells/µl, sensitivity 67,65%, specificity: 78.57%, AUC: 0.7850, p < 0.0001; CD3 + CD4+: < 369 cells/µl, sensitivity 76.47%, specificity: 75.40%, AUC: 0.7697, p < 0.0001; CD3 + CD8+: < 194 cells/µl, sensitivity 73.53%, specificity: 70.63%, AUC: 0.7800, p < 0.0001; CD3 + CD4 + CD8 + DP: < 6.5 cells/µl, sensitivity 73.53%, specificity: 73.02%, AUC: 0.7715, p < 0.0001; CD3 + CD4 − CD8 − DN: < 21.5 cells/µl, sensitivity 76.47%, specificity: 68.25%, AUC: 0.7674, p < 0.0001. ( B ) ROC analysis showing the performance of baseline absolute counts of total T lymphocytes and their subsets in distinguishing severe (NRM, NIV and OTI) from nonsevere (AA and VMK) cases. Cutoff value for: CD3+ : < 733 cells/µl, sensitivity 69.44%, specificity: 73.86%, AUC: 0.7295, p < 0.0001; CD3 + CD4+ : < 426 cells/µl, sensitivity 62.50%, specificity: 72.73%, AUC: 0.6862, p < 0.0001; CD3 + CD8+ : < 262 cells/µl, sensitivity 73.61%, specificity: 64.77%, AUC: 0.7483, p < 0.0001; CD3 + CD4 + CD8 + DP: < 4.5 cells/µl, sensitivity 41.67%, specificity: 90.91%, AUC: 0.7148, p < 0.0001; CD3 + CD4 − CD8 − DN: < 18.5 cells/µl, sensitivity 56.94%, specificity: 84.09%, AUC: 0.7319, p < 0.0001. AUC area under the curve, AA ambient air, VMK Venturi mask, NRM nonrebreather oxygen mask with concentrator, NIV noninvasive mechanical ventilation, OTI Orotracheal Intubation for mechanical ventilation.

Journal: Scientific Reports

Article Title: Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in SARS-CoV-2 infected patients: a single center study

doi: 10.1038/s41598-021-90983-0

Figure Lengend Snippet: ROC analysis of T-lymphocyte subset absolute counts for in-hospital mortality and disease severity of COVID-19 patients. Receiver operating characteristic (ROC) curves are represented for total CD3+ and four subsets of T lymphocyte cells. Cutoff values were identified with the Youden’s index. ( A ) ROC analysis showing the performance of baseline absolute counts of total T lymphocyte and their subsets in distinguishing fatal cases from survivors. Cutoff values for: CD3+: 524 cells/µl, sensitivity 67,65%, specificity: 78.57%, AUC: 0.7850, p < 0.0001; CD3 + CD4+: < 369 cells/µl, sensitivity 76.47%, specificity: 75.40%, AUC: 0.7697, p < 0.0001; CD3 + CD8+: < 194 cells/µl, sensitivity 73.53%, specificity: 70.63%, AUC: 0.7800, p < 0.0001; CD3 + CD4 + CD8 + DP: < 6.5 cells/µl, sensitivity 73.53%, specificity: 73.02%, AUC: 0.7715, p < 0.0001; CD3 + CD4 − CD8 − DN: < 21.5 cells/µl, sensitivity 76.47%, specificity: 68.25%, AUC: 0.7674, p < 0.0001. ( B ) ROC analysis showing the performance of baseline absolute counts of total T lymphocytes and their subsets in distinguishing severe (NRM, NIV and OTI) from nonsevere (AA and VMK) cases. Cutoff value for: CD3+ : < 733 cells/µl, sensitivity 69.44%, specificity: 73.86%, AUC: 0.7295, p < 0.0001; CD3 + CD4+ : < 426 cells/µl, sensitivity 62.50%, specificity: 72.73%, AUC: 0.6862, p < 0.0001; CD3 + CD8+ : < 262 cells/µl, sensitivity 73.61%, specificity: 64.77%, AUC: 0.7483, p < 0.0001; CD3 + CD4 + CD8 + DP: < 4.5 cells/µl, sensitivity 41.67%, specificity: 90.91%, AUC: 0.7148, p < 0.0001; CD3 + CD4 − CD8 − DN: < 18.5 cells/µl, sensitivity 56.94%, specificity: 84.09%, AUC: 0.7319, p < 0.0001. AUC area under the curve, AA ambient air, VMK Venturi mask, NRM nonrebreather oxygen mask with concentrator, NIV noninvasive mechanical ventilation, OTI Orotracheal Intubation for mechanical ventilation.

Article Snippet: Lymphocyte subpopulations were assessed using BD Multitest™ 6-color TBNK (FITC-labeled CD3 clone SK7; PE-labeled CD16, clone B73.1, and CD56, clone NCAM 16.2; PerCP-Cy™5.5-labeled CD45, clone 2D1; PE-Cy™7-labeled CD4, clone SK3; APC-labeled CD19, clone SJ25C1; APC-Cy7-labeled CD8, clone SK1) and BD Trucount™ tubes for absolute count with a lyse-no-wash procedure (BD FACS™Lysing Solution).

Techniques:

Lymphocyte subset absolute counts in the five groups of patients stratified according to maximal oxygen supply/ventilation support. Absolute counts of total T-lymphocytes (CD3+, ( A ) and related subsets (CD3 + CD4+, ( B ) CD3 + CD8+, ( C ) CD3 + CD4 + CD8 + DP, ( D ) CD3 + CD4 − CD8 − DN, ( E ) CD4/CD8 ratio ( F ) B-lymphocytes (CD19+, ( G ) and NK-cells (CD3 neg CD16 + CD56+, ( H ) in the study population after stratification according to maximal oxygen supply/ventilation support required during hospitalization. Differences were analyzed using the Kruskal–Wallis and Dunn’s multiple comparison tests; the AA group was used as a reference group for multiple comparisons. Patients were further grouped into nonsevere (AA and VMK, blue dashed line box) and severe (NRM, NIV and OTI, red dashed line box); differences were analyzed using the Mann–Whitney test. A two-sided p value of < 0.05 was considered statistically significant. AA ambient air, VMK Venturi mask, NRM nonrebreather oxygen mask with concentrator, NIV noninvasive mechanical ventilation, OTI Orotracheal Intubation for mechanical ventilation. *0.01 < p < 0.5; **0.001 < p < 0.01; ***0.0001 < p < 0.00001; ****p < 0.0001.

Journal: Scientific Reports

Article Title: Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in SARS-CoV-2 infected patients: a single center study

doi: 10.1038/s41598-021-90983-0

Figure Lengend Snippet: Lymphocyte subset absolute counts in the five groups of patients stratified according to maximal oxygen supply/ventilation support. Absolute counts of total T-lymphocytes (CD3+, ( A ) and related subsets (CD3 + CD4+, ( B ) CD3 + CD8+, ( C ) CD3 + CD4 + CD8 + DP, ( D ) CD3 + CD4 − CD8 − DN, ( E ) CD4/CD8 ratio ( F ) B-lymphocytes (CD19+, ( G ) and NK-cells (CD3 neg CD16 + CD56+, ( H ) in the study population after stratification according to maximal oxygen supply/ventilation support required during hospitalization. Differences were analyzed using the Kruskal–Wallis and Dunn’s multiple comparison tests; the AA group was used as a reference group for multiple comparisons. Patients were further grouped into nonsevere (AA and VMK, blue dashed line box) and severe (NRM, NIV and OTI, red dashed line box); differences were analyzed using the Mann–Whitney test. A two-sided p value of < 0.05 was considered statistically significant. AA ambient air, VMK Venturi mask, NRM nonrebreather oxygen mask with concentrator, NIV noninvasive mechanical ventilation, OTI Orotracheal Intubation for mechanical ventilation. *0.01 < p < 0.5; **0.001 < p < 0.01; ***0.0001 < p < 0.00001; ****p < 0.0001.

Article Snippet: Lymphocyte subpopulations were assessed using BD Multitest™ 6-color TBNK (FITC-labeled CD3 clone SK7; PE-labeled CD16, clone B73.1, and CD56, clone NCAM 16.2; PerCP-Cy™5.5-labeled CD45, clone 2D1; PE-Cy™7-labeled CD4, clone SK3; APC-labeled CD19, clone SJ25C1; APC-Cy7-labeled CD8, clone SK1) and BD Trucount™ tubes for absolute count with a lyse-no-wash procedure (BD FACS™Lysing Solution).

Techniques: MANN-WHITNEY

Univariable and multivariable logistic regression analysis for in-hospital mortality-related risks in patients with SARS-CoV-2 infection.

Journal: Scientific Reports

Article Title: Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in SARS-CoV-2 infected patients: a single center study

doi: 10.1038/s41598-021-90983-0

Figure Lengend Snippet: Univariable and multivariable logistic regression analysis for in-hospital mortality-related risks in patients with SARS-CoV-2 infection.

Article Snippet: Lymphocyte subpopulations were assessed using BD Multitest™ 6-color TBNK (FITC-labeled CD3 clone SK7; PE-labeled CD16, clone B73.1, and CD56, clone NCAM 16.2; PerCP-Cy™5.5-labeled CD45, clone 2D1; PE-Cy™7-labeled CD4, clone SK3; APC-labeled CD19, clone SJ25C1; APC-Cy7-labeled CD8, clone SK1) and BD Trucount™ tubes for absolute count with a lyse-no-wash procedure (BD FACS™Lysing Solution).

Techniques: Infection

Univariable and multivariable logistic regression analysis for severity-related risks in patients with SARS-CoV-2 infection.

Journal: Scientific Reports

Article Title: Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in SARS-CoV-2 infected patients: a single center study

doi: 10.1038/s41598-021-90983-0

Figure Lengend Snippet: Univariable and multivariable logistic regression analysis for severity-related risks in patients with SARS-CoV-2 infection.

Article Snippet: Lymphocyte subpopulations were assessed using BD Multitest™ 6-color TBNK (FITC-labeled CD3 clone SK7; PE-labeled CD16, clone B73.1, and CD56, clone NCAM 16.2; PerCP-Cy™5.5-labeled CD45, clone 2D1; PE-Cy™7-labeled CD4, clone SK3; APC-labeled CD19, clone SJ25C1; APC-Cy7-labeled CD8, clone SK1) and BD Trucount™ tubes for absolute count with a lyse-no-wash procedure (BD FACS™Lysing Solution).

Techniques: Infection

Correlation between lymphocyte subpopulation absolute counts and inflammation markers. Absolute counts of total T-lymphocytes and related subsets (CD3 + CD4+, CD3 + CD8+, CD3 + CD4 + CD8 + DP, CD3 + CD4 − CD8 − DN), B-lymphocytes and NK-cells (CD16 + CD56+) were correlated with IL-6 (column A), CRP serum concentrations (column B) and d -dimer plasma concentration (column C). Correlation was assessed with the Spearman’s test; Spearman r (only if statistically significant) and p are reported in the boxes; a two-sided p value of < 0.05 was considered statistically significant. ns not statistically significant, IL-6 interleukin-6, CRP C-reactive protein.

Journal: Scientific Reports

Article Title: Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in SARS-CoV-2 infected patients: a single center study

doi: 10.1038/s41598-021-90983-0

Figure Lengend Snippet: Correlation between lymphocyte subpopulation absolute counts and inflammation markers. Absolute counts of total T-lymphocytes and related subsets (CD3 + CD4+, CD3 + CD8+, CD3 + CD4 + CD8 + DP, CD3 + CD4 − CD8 − DN), B-lymphocytes and NK-cells (CD16 + CD56+) were correlated with IL-6 (column A), CRP serum concentrations (column B) and d -dimer plasma concentration (column C). Correlation was assessed with the Spearman’s test; Spearman r (only if statistically significant) and p are reported in the boxes; a two-sided p value of < 0.05 was considered statistically significant. ns not statistically significant, IL-6 interleukin-6, CRP C-reactive protein.

Article Snippet: Lymphocyte subpopulations were assessed using BD Multitest™ 6-color TBNK (FITC-labeled CD3 clone SK7; PE-labeled CD16, clone B73.1, and CD56, clone NCAM 16.2; PerCP-Cy™5.5-labeled CD45, clone 2D1; PE-Cy™7-labeled CD4, clone SK3; APC-labeled CD19, clone SJ25C1; APC-Cy7-labeled CD8, clone SK1) and BD Trucount™ tubes for absolute count with a lyse-no-wash procedure (BD FACS™Lysing Solution).

Techniques: Concentration Assay

T-, B- and NK-lymphocyte subpopulation absolute counts at baseline after patient stratification according to maximal oxygen supply/ventilation support.

Journal: Scientific Reports

Article Title: Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in SARS-CoV-2 infected patients: a single center study

doi: 10.1038/s41598-021-90983-0

Figure Lengend Snippet: T-, B- and NK-lymphocyte subpopulation absolute counts at baseline after patient stratification according to maximal oxygen supply/ventilation support.

Article Snippet: Lymphocyte subpopulations were assessed using BD Multitest™ 6-color TBNK (FITC-labeled CD3 clone SK7; PE-labeled CD16, clone B73.1, and CD56, clone NCAM 16.2; PerCP-Cy™5.5-labeled CD45, clone 2D1; PE-Cy™7-labeled CD4, clone SK3; APC-labeled CD19, clone SJ25C1; APC-Cy7-labeled CD8, clone SK1) and BD Trucount™ tubes for absolute count with a lyse-no-wash procedure (BD FACS™Lysing Solution).

Techniques: